Desq Long
Sign in

Company

Dianthus Therapeutics, Inc. /DE/

DNTH · CIK 0001690585

SEC FORM 4
$357,600.00

Dianthus Therapeutics, Inc. /DE/ (DNTH)

Acquisition (code M) of 20,000 shares at $17.88 per share.

Reporting Person CARR EDWARD · Officer Title CHIEF ACCOUNTING OFFICER · Transaction Code M

Traded Sep 17, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001273351-26-000006 · filed 2026-09-18 · View filing →

SEC FORM 4
$796,209.04

Dianthus Therapeutics, Inc. /DE/ (DNTH)

Sale of 7,928 shares at $100.43 per share.

Reporting Person CARR EDWARD · Officer Title CHIEF ACCOUNTING OFFICER · Transaction Code S

Traded Sep 17, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001273351-26-000006 · filed 2026-09-18 · View filing →

SEC FORM 4
$686,376.27

Dianthus Therapeutics, Inc. /DE/ (DNTH)

Sale of 6,771 shares at $101.37 per share.

Reporting Person CARR EDWARD · Officer Title CHIEF ACCOUNTING OFFICER · Transaction Code S

Traded Sep 17, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001273351-26-000006 · filed 2026-09-18 · View filing →

SEC FORM 4
$358,467.39

Dianthus Therapeutics, Inc. /DE/ (DNTH)

Sale of 3,501 shares at $102.39 per share.

Reporting Person CARR EDWARD · Officer Title CHIEF ACCOUNTING OFFICER · Transaction Code S

Traded Sep 17, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001273351-26-000006 · filed 2026-09-18 · View filing →

SEC FORM 4
$113,520.00

Dianthus Therapeutics, Inc. /DE/ (DNTH)

Sale of 1,100 shares at $103.20 per share.

Reporting Person CARR EDWARD · Officer Title CHIEF ACCOUNTING OFFICER · Transaction Code S

Traded Sep 17, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001273351-26-000006 · filed 2026-09-18 · View filing →

SEC FORM 4
$73,073.00

Dianthus Therapeutics, Inc. /DE/ (DNTH)

Sale of 700 shares at $104.39 per share.

Reporting Person CARR EDWARD · Officer Title CHIEF ACCOUNTING OFFICER · Transaction Code S

Traded Sep 17, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001273351-26-000006 · filed 2026-09-18 · View filing →

SEC FORM 4
$134,100.00

Dianthus Therapeutics, Inc. /DE/ (DNTH)

Acquisition (code M) of 7,500 shares at $17.88 per share.

Reporting Person Randhawa Simrat · Officer Title EVP, Head of R&D · Transaction Code M

Traded Sep 1, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001992260-26-000009 · filed 2026-09-03 · View filing →

SEC FORM 4
$136,040.73

Dianthus Therapeutics, Inc. /DE/ (DNTH)

Acquisition (code M) of 6,249 shares at $21.77 per share.

Reporting Person Randhawa Simrat · Officer Title EVP, Head of R&D · Transaction Code M

Traded Sep 1, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001992260-26-000009 · filed 2026-09-03 · View filing →

SEC FORM 4
$206,906.25

Dianthus Therapeutics, Inc. /DE/ (DNTH)

Acquisition (code M) of 9,375 shares at $22.07 per share.

Reporting Person Randhawa Simrat · Officer Title EVP, Head of R&D · Transaction Code M

Traded Sep 1, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001992260-26-000009 · filed 2026-09-03 · View filing →

SEC FORM 4
$273,494.00

Dianthus Therapeutics, Inc. /DE/ (DNTH)

Sale of 2,600 shares at $105.19 per share.

Reporting Person Randhawa Simrat · Officer Title EVP, Head of R&D · Transaction Code S

Traded Sep 1, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001992260-26-000009 · filed 2026-09-03 · View filing →

SEC FORM 4
$766,593.75

Dianthus Therapeutics, Inc. /DE/ (DNTH)

Sale of 7,215 shares at $106.25 per share.

Reporting Person Randhawa Simrat · Officer Title EVP, Head of R&D · Transaction Code S

Traded Sep 1, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001992260-26-000009 · filed 2026-09-03 · View filing →

SEC FORM 4
$1,420,602.66

Dianthus Therapeutics, Inc. /DE/ (DNTH)

Sale of 13,309 shares at $106.74 per share.

Reporting Person Randhawa Simrat · Officer Title EVP, Head of R&D · Transaction Code S

Traded Sep 1, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001992260-26-000009 · filed 2026-09-03 · View filing →

SEC FORM 4
$51,004.08

Dianthus Therapeutics, Inc. /DE/ (DNTH)

Acquisition (code M) of 2,778 shares at $18.36 per share.

Reporting Person Read Simon · Transaction Code M

Traded Aug 19, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0001688199-26-000006 · filed 2026-08-19 · View filing →

SEC FORM 4
$326,553.90

Dianthus Therapeutics, Inc. /DE/ (DNTH)

Sale of 2,778 shares at $117.55 per share.

Reporting Person Read Simon · Transaction Code S

Traded Aug 19, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0001688199-26-000006 · filed 2026-08-19 · View filing →

SEC FORM 4
$272,550.00

Dianthus Therapeutics, Inc. /DE/ (DNTH)

Acquisition (code M) of 15,000 shares at $18.17 per share.

Reporting Person Veness Adam M · Officer Title SVP, General Counsel and Sec. · Transaction Code M

Traded Aug 13, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0001778623-26-000009 · filed 2026-08-14 · View filing →